1569-16-0, In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 1569-16-0, name is 2-Methyl[1,8]-Naphthyridine, introducing its new discovery.
Pharmacia Corporation
The present invention relates to a class of compounds represented by the Formula I or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising compounds of the Formula I, and methods of selectively inhibiting or antagonizing the alphavbeta3 and/or alphavbeta5 integrin.
Note that a catalyst decreases the activation energy for both the forward and the reverse reactions and hence accelerates both the forward and the reverse reactions.1569-16-0, you can also check out more blogs about1569-16-0
Reference£º
1,323-Naphthyridine – Wikipedia,
1,8-Naphthyridine | C8H6N317 – PubChem